0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncol. Published online June 23, 2016. doi:10.1001/jamaoncol.2016.0283

JAMA Oncology | 
Review |  ONLINE FIRST
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Oncol. Published online June 23, 2016. doi:10.1001/jamaoncol.2016.1061
Includes: Supplemental Content

JAMA Cardiology | 
Brief Report |  FREE ONLINE FIRST
Gregg C. Fonarow, MD; Adrian F. Hernandez, MD, MHS; Scott D. Solomon, MD; et al.
JAMA Cardiol. Published online June 22, 2016. doi:10.1001/jamacardio.2016.1724

JAMA Oncology | 
Research Letter |  ONLINE FIRST
David Liu, MD, MPH, MS; Elizabeth R. Plimack, MD, MS; Jean Hoffman-Censits, MD; et al.
JAMA Oncol. Published online June 16, 2016. doi:10.1001/jamaoncol.2016.1056

JAMA Oncology | 
Review |  ONLINE FIRST
Adrian G. Sacher, MD; Leena Gandhi, MD, PhD
JAMA Oncol. Published online June 16, 2016. doi:10.1001/jamaoncol.2016.0639

JAMA Oncology | 
Editorial |  ONLINE FIRST
Mitchell Dowsett, PhD, FMedSci
JAMA Oncol. Published online June 09, 2016. doi:10.1001/jamaoncol.2016.0983

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Aleix Prat, MD, PhD; Maggie C. U. Cheang, PhD; Patricia Galván, BS; et al.
JAMA Oncol. Published online June 09, 2016. doi:10.1001/jamaoncol.2016.0922
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Axel Grothey, MD; Daniel J. Sargent, PhD
JAMA Oncol. Published online June 06, 2016. doi:10.1001/jamaoncol.2016.2304

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Maria Schwaederle, PharmD; Melissa Zhao, BS; J. Jack Lee, PhD; et al.
JAMA Oncol. Published online June 06, 2016. doi:10.1001/jamaoncol.2016.2129
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Nan Song, PhD; Katherine L. Pogue-Geile, PhD; Patrick G. Gavin, BS; et al.
JAMA Oncol. Published online June 06, 2016. doi:10.1001/jamaoncol.2016.2314
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Cardiology
Brief Report  | 
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure
Gregg C. Fonarow, MD; Adrian F. Hernandez, MD, MHS; Scott D. Solomon, MD; et al.
JAMA Oncology
Research Letter  | 
Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma
David Liu, MD, MPH, MS; Elizabeth R. Plimack, MD, MS; Jean Hoffman-Censits, MD; et al.